Tier IIILignan · anxiolytic42 trials

Magnolia (honokiol/magnolol) — The Neuroprotective Anxiolytic

Magnolia bark extract, rich in the bioactive lignans honokiol and magnolol, is traditionally used for its anxiolytic and sleep-promoting properties. In the context of longevity, these compounds are studied for their potent antioxidant, anti-inflammatory, and neuroprotective effects, particularly their ability to modulate GABA receptors and activate SIRT3.

Mechanism of Action

Honokiol and magnolol act as positive allosteric modulators of GABA_A receptors, promoting relaxation and sleep without the dependency risks of benzodiazepines. Beyond neuroinhibition, honokiol is a notable activator of SIRT3, a mitochondrial sirtuin that enhances mitochondrial function and reduces oxidative stress. Both compounds also inhibit NF-κB signaling, thereby reducing neuroinflammation and systemic inflammatory cytokines. Additionally, they exhibit potent free radical scavenging activity, protecting cellular membranes and DNA from oxidative damage.

Human Trial Evidence

Human clinical trials primarily focus on the anxiolytic and sleep-enhancing effects of Magnolia bark extract, often in combination with other botanicals like Phellodendron. Studies demonstrate significant reductions in perceived stress and salivary cortisol levels. However, there are no published human longevity trials specifically evaluating honokiol or magnolol for lifespan extension; evidence for these endpoints remains limited to animal and in-vitro models.

Dosing Protocol

Typical dosing for Magnolia bark extract standardized to honokiol and magnolol ranges from 200 to 400 mg per day, often taken in the evening to support sleep. For pure honokiol extracts, doses of 200 mg up to 1,000 mg daily have been used in clinical practice, though optimal dosing for longevity purposes is unestablished. It is best taken with a fat source to enhance absorption.

Safety & Contraindications

Magnolia bark extract is generally well-tolerated at standard doses. Adverse effects are rare but may include mild gastrointestinal distress or daytime drowsiness if taken in the morning. It should be used with caution or avoided in individuals taking sedative medications, benzodiazepines, or alcohol due to potential synergistic CNS depression. Safety in pregnancy and lactation is not established.

Key Papers

Quick Stats
Evidence TierTier III
Clinical Trials42
Typical Dose250 mg
Est. Cost/Day$0.42
Purity98.0%
Synergistic Compounds
L-TheanineApigeninMagnesium ThreonateAshwagandha
Medical disclaimer: This page is for informational purposes only. Consult a qualified healthcare provider before starting any supplement regimen. Vitaei does not provide medical advice.